Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Shao-Liang Zhu"'
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 8, Iss 2, Pp n/a-n/a (2020)
Abstract Background There have been many reports on midkine as a promising marker in the diagnosis of hepatocellular carcinoma (HCC). However, the results are inconsistent and even conflicting. Methods This meta‐analysis was performed to investigat
Externí odkaz:
https://doaj.org/article/daa20e847600419ba37b11cf10841f74
Autor:
Fei-Xiang Wu, Jie Chen, Tao Bai, Shao-Liang Zhu, Tian-Bo Yang, Lu-Nan Qi, Ling Zou, Zi-Hui Li, Jia-Zhou Ye, Le-Qun Li
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background Sorafenib and transarterial chemoembolization (TACE) are recommended therapies for advanced hepatocellular carcinoma (HCC), but their combined efficacy remains unclear. Methods Between August 2004 and November 2014, 104 patients w
Externí odkaz:
https://doaj.org/article/7758fe4134b04e4f87b37ea60b59bbdb
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e115834 (2014)
BackgroundThe aim of this study was to compare the long-term outcome of patients with a solitary large (> 5 cm) hepatocellular carcinoma (HCC) in Barcelona Clinic Liver Cancer (BCLC) stage A who received liver resection (LR) or transarterial chemoemb
Externí odkaz:
https://doaj.org/article/d4012718b4ac4e5ea7d284ac95bc28d8
Autor:
Guo-bin Wu, Bang-De Xiang, Hao Huang, Shao-Liang Zhu, Jingrong He, Jian-Hong Zhong, Yi-shuai Mo, Fei-Xiang Wu, Ning-Fu Peng, Jindu Li, Le-Qun Li, Hang Ye, Xianmao Shi
Publikováno v:
Cell Biology International. 44:1103-1111
Dysregulation of genes involved in alternative splicing contributes to hepatocarcinogenesis. SNRPB, a component of spliceosome, is implicated in human cancers, yet its clinical significance and biological function in hepatocellular carcinoma (HCC) re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d58a16230fba793cf02fada14d9f9551
https://doi.org/10.1002/cbin.11307
https://doi.org/10.1002/cbin.11307
Publikováno v:
Journal of Oncology, Vol 2021 (2021)
Objective. To investigate the expression of transient receptor potential (TRP) superfamily genes, especially TRPC7-AS1 in hepatitis B virus- (HBV-) related hepatocellular carcinoma (HCC). Methods. Three cancer samples of HBV-related HCC at phase IV a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef4f0553b6f27539b4ecbf6f2b282816
Publikováno v:
Cancer Biol Ther
This study aimed to investigate the influence of miR-221-3p and O(6)-methylguanine-DNA methyltransferase (MGMT) interaction in human hepatocellular carcinoma (HCC), thereby revealing a novel molecular mechanism of hepatic carcinogenesis involving miR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6af6d8232679310ba342ccb8e7e5b741
https://pubmed.ncbi.nlm.nih.gov/33023393
https://pubmed.ncbi.nlm.nih.gov/33023393
Autor:
Jiazhou Ye, Tao Bai, Fei-Xiang Wu, Le-Qun Li, Zi-Hui Li, Jie Chen, Jun-Ze Chen, Shao-Liang Zhu
Publikováno v:
World Journal of Gastroenterology
AIM To investigate the efficacy and safety of postoperative adjuvant transcatheter arterial chemoembolization (PA-TACE) in preventing tumor recurrence and improving survival in Barcelona Clinic Liver Cancer (BCLC) early (A) and intermediate (B) stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da5cee7184d0e59e663e88c787229186
http://europepmc.org/articles/PMC5685847
http://europepmc.org/articles/PMC5685847
Publikováno v:
Oncotarget
// Jie Ma 1, * , Shao-Liang Zhu 2, * , Yang Liu 3, * , Xiang-Yang Huang 1 and Dan-Ke Su 1 1 Department of Radiology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China 2 Department of Hepatobiliary Surgery, Affiliated Tumor Hospi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9fac4104d228538995bfdf947ac3f4c
https://doi.org/10.18632/oncotarget.18513
https://doi.org/10.18632/oncotarget.18513
Autor:
Fei-Xiang Wu, Shao-Liang Zhu, Jie Chen, Ling Zou, Tian-Bo Yang, Tao Bai, Hui-Rong Lu, Zi-Hui Li, Shi-Xiong Liang
Publikováno v:
OncoTargets and therapy
Fei-Xiang Wu,1–3,* Hui-Rong Lu,4,* Shao-Liang Zhu,1,* Zi-Hui Li,1 Ling Zou,1 Tao Bai,1 Jie Chen,1 Tian-Bo Yang,1 Shi-Xiong Liang4,51Department of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, 2Guangxi Live
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f60f6e927dd0c09ca8e105e2eab1488d
https://doi.org/10.2147/ott.s113161
https://doi.org/10.2147/ott.s113161
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 8, Iss 2, Pp n/a-n/a (2020)
Molecular Genetics & Genomic Medicine
Molecular Genetics & Genomic Medicine
Background There have been many reports on midkine as a promising marker in the diagnosis of hepatocellular carcinoma (HCC). However, the results are inconsistent and even conflicting. Methods This meta‐analysis was performed to investigate the acc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5b296fb075201875e7510ef73731740
https://doi.org/10.1002/mgg3.1071
https://doi.org/10.1002/mgg3.1071